• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清胃蛋白酶原I与II比值在胃癌筛查中的作用

Role of Serum Pepsinogen I and II Ratio in Screening of Gastric Carcinoma.

作者信息

Begum A, Baten M A, Begum Z, Ahsan M M, Rahman S F, Chowdhury F, Khan A H

机构信息

Dr Ambia Begum, Assistant Professor, Department of Pathology, Community Based Medical College Bangladesh (CBMCB), Mymensingh, Bangladesh.

出版信息

Mymensingh Med J. 2017 Jul;26(3):628-634.

PMID:28919620
Abstract

In spite of the global decline in its incidence and mortality, gastric carcinoma still remains a major cause of death due to cancer. Early detection of gastric carcinoma is expected to reduce mortality rates. The applications of measuring of pepsinogen I and pepsinogen II are useful in screening of gastric carcinoma. This cross sectional comparative study was done to find out the correlation of histopathological pattern of gastric carcinoma with serum pepsinogen I & II ratio in the Department of Pathology, Sylhet MAG Osmani Medical College, Sylhet, Bangladesh from January 2010 to December 2010. For these purpose 40 patients with gastric carcinoma, endoscopically visible and histopathologically proved malignant lesions were enrolled as case group. Forty subjects with normal upper GI endoscopy were taken as control. Five ml of venous blood was taken from both case and control subjects to determine serum pepsinogen I and pepsinogen II level by ELISA method, subsequently pepsinogen I and II ratio was calculated. In this study different cut off values of serum pepsinogen I and II ratio was determined and the sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 70.0%, 97.5% 96.6% 76.5% and 83.8% respectively, at cut off value of 6. Which is the most suitable cut off point of serum pepsinogen I and II ratio for gastric cancer screening.

摘要

尽管全球胃癌的发病率和死亡率有所下降,但它仍然是癌症死亡的主要原因。早期发现胃癌有望降低死亡率。胃蛋白酶原I和胃蛋白酶原II检测的应用有助于胃癌筛查。本横断面比较研究于2010年1月至2010年12月在孟加拉国锡尔赫特MAG奥斯曼尼医学院病理科进行,旨在找出胃癌组织病理学模式与血清胃蛋白酶原I和II比值之间的相关性。为此,将40例经内镜可见且组织病理学证实为恶性病变的胃癌患者纳入病例组。选取40例上消化道内镜检查正常的受试者作为对照组。从病例组和对照组受试者中各采集5毫升静脉血,采用酶联免疫吸附测定法测定血清胃蛋白酶原I和胃蛋白酶原II水平,随后计算胃蛋白酶原I和II的比值。本研究确定了血清胃蛋白酶原I和II比值的不同临界值,在临界值为6时,其灵敏度、特异度、阳性预测值、阴性预测值和准确度分别为70.0%、97.5%、96.6%、76.5%和83.8%。这是用于胃癌筛查的血清胃蛋白酶原I和II比值的最合适临界值。

相似文献

1
Role of Serum Pepsinogen I and II Ratio in Screening of Gastric Carcinoma.血清胃蛋白酶原I与II比值在胃癌筛查中的作用
Mymensingh Med J. 2017 Jul;26(3):628-634.
2
Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach.各种胃部疾病中的血清胃蛋白酶原I和II水平,特别提及它们作为胃癌筛查试验的用途。
Trop Gastroenterol. 2007 Oct-Dec;28(4):166-70.
3
[Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].[血清胃蛋白酶原异常用于筛查慢性萎缩性胃炎和胃癌的界值研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2006 Oct;27(10):840-4.
4
Gastric cancer screening using the serum pepsinogen test method.采用血清胃蛋白酶原检测方法进行胃癌筛查。
Gastric Cancer. 2006;9(4):245-53. doi: 10.1007/s10120-006-0397-0. Epub 2006 Nov 24.
5
Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening.胃蛋白酶原检测用于胃癌、发育异常或慢性萎缩性胃炎筛查有效性的Meta分析。
J Med Screen. 2004;11(3):141-7. doi: 10.1258/0969141041732184.
6
[Evaluation of serum pepsinogen I , II and osteopontin co-detection in gastric cancer screening].[血清胃蛋白酶原I、II及骨桥蛋白联合检测在胃癌筛查中的评估]
Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):691-3.
7
Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.胃癌患者亲属的血清胃蛋白酶原I、胃蛋白酶原II和胃泌素17:与胃炎类型和严重程度的比较研究
Clin Gastroenterol Hepatol. 2008 Feb;6(2):174-9. doi: 10.1016/j.cgh.2007.11.016.
8
Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer.基于人群的早期胃癌筛查中血清胃蛋白酶原 I、胃蛋白酶原 II 和胃泌素-17 水平的诊断价值。
J Int Med Res. 2020 Mar;48(3):300060520914826. doi: 10.1177/0300060520914826.
9
[Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].[胃癌高发区居民血清胃蛋白酶原水平与胃黏膜变化的相关性]
Zhonghua Zhong Liu Za Zhi. 2006 Jul;28(7):507-11.
10
Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1beta-511 polymorphisms are independent risk factors for gastric cancer in Thais.幽门螺杆菌感染与血清胃蛋白酶原I/II比值及白细胞介素-1β -511基因多态性相结合是泰国人患胃癌的独立危险因素。
J Gastroenterol. 2006 Dec;41(12):1169-77. doi: 10.1007/s00535-006-1951-6. Epub 2007 Feb 6.

引用本文的文献

1
A Machine Learning-Driven Surface-Enhanced Raman Scattering Analysis Platform for the Label-Free Detection and Identification of Gastric Lesions.一种基于机器学习的表面增强拉曼散射分析平台,用于无标记检测和识别胃部病变。
Int J Nanomedicine. 2024 Sep 10;19:9305-9315. doi: 10.2147/IJN.S471392. eCollection 2024.
2
Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations.血清胃蛋白酶原作为南亚和东南亚人群胃癌和胃炎的生物标志物。
PLoS One. 2020 Apr 9;15(4):e0230064. doi: 10.1371/journal.pone.0230064. eCollection 2020.
3
Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer.
血清 miR-101-3p 联合胃蛋白酶原有助于胃癌的早期诊断。
BMC Med Genet. 2020 Feb 10;21(1):28. doi: 10.1186/s12881-020-0967-8.
4
The Value of Pepsinogen in GC Screening: A Systematic Review and Meta-Analysis.胃蛋白酶原在胃癌筛查中的价值:一项系统评价与Meta分析
Gastroenterol Res Pract. 2019 Jan 21;2019:7087232. doi: 10.1155/2019/7087232. eCollection 2019.